A detailed history of Bessemer Group Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 1,900,918 shares of MRK stock, worth $185 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,900,918
Previous 1,884,201 0.89%
Holding current value
$185 Million
Previous $233 Million 7.46%
% of portfolio
0.36%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $1.86 Million - $2.16 Million
16,717 Added 0.89%
1,900,918 $216 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $5.3 Million - $5.69 Million
-42,824 Reduced 2.22%
1,884,201 $233 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $32.4 Million - $37.7 Million
285,852 Added 17.42%
1,927,025 $254 Million
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $1.68 Million - $1.83 Million
16,749 Added 1.03%
1,641,173 $179 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $911,519 - $1.01 Million
-8,854 Reduced 0.54%
1,624,424 $167 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $18.4 Million - $20 Million
169,319 Added 11.57%
1,633,278 $188 Million
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $1.38 Million - $1.54 Million
13,388 Added 0.92%
1,463,959 $156 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $1.44 Million - $1.84 Million
16,450 Added 1.15%
1,450,571 $161 Million
Q3 2022

Nov 09, 2022

BUY
$84.53 - $94.96 $2.02 Million - $2.27 Million
23,896 Added 1.69%
1,434,121 $124 Million
Q2 2022

Aug 10, 2022

BUY
$83.49 - $94.64 $4.42 Million - $5.01 Million
52,934 Added 3.9%
1,410,225 $129 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $2.11 Million - $2.37 Million
28,744 Added 2.16%
1,357,291 $111 Million
Q4 2021

Jan 27, 2022

SELL
$72.28 - $90.54 $20.2 Million - $25.3 Million
-279,784 Reduced 17.4%
1,328,547 $102 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $719,308 - $791,059
10,035 Added 0.63%
1,608,331 $121 Million
Q2 2021

Aug 06, 2021

BUY
$70.31 - $77.77 $21.2 Million - $23.4 Million
301,277 Added 23.23%
1,598,296 $124 Million
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $4.54 Million - $5.34 Million
65,898 Added 5.35%
1,297,019 $95.4 Million
Q4 2020

Feb 09, 2021

BUY
$71.77 - $79.65 $426,026 - $472,802
5,936 Added 0.48%
1,231,121 $101 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $7.99 Million - $9.05 Million
109,158 Added 9.78%
1,225,185 $102 Million
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $2.99 Million - $3.41 Million
42,521 Added 3.96%
1,116,027 $86.3 Million
Q1 2020

Apr 30, 2020

BUY
$63.36 - $87.82 $8.34 Million - $11.6 Million
131,695 Added 13.98%
1,073,506 $82.6 Million
Q4 2019

Feb 04, 2020

SELL
$77.58 - $87.54 $1.58 Million - $1.78 Million
-20,331 Reduced 2.11%
941,811 $85.7 Million
Q3 2019

Nov 07, 2019

BUY
$76.08 - $82.93 $1.52 Million - $1.65 Million
19,955 Added 2.12%
962,142 $81 Million
Q2 2019

Jul 19, 2019

BUY
$69.84 - $81.59 $10.5 Million - $12.2 Million
150,070 Added 18.95%
942,187 $79 Million
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $1.51 Million - $1.72 Million
21,701 Added 2.82%
792,117 $65.9 Million
Q4 2018

Feb 12, 2019

BUY
$65.24 - $75.71 $45.6 Million - $52.9 Million
698,622 Added 973.09%
770,416 $58.9 Million
Q3 2018

Nov 06, 2018

BUY
$57.69 - $67.84 $197,530 - $232,284
3,424 Added 5.01%
71,794 $5.09 Million
Q2 2018

Jul 25, 2018

SELL
$50.83 - $59.72 $1.06 Million - $1.25 Million
-20,860 Reduced 23.38%
68,370 $4.15 Million
Q1 2018

May 10, 2018

SELL
$50.96 - $59.23 $48.3 Million - $56.1 Million
-947,111 Reduced 91.39%
89,230 $4.86 Million
Q4 2017

Jan 30, 2018

SELL
$51.62 - $61.64 $206,841 - $246,991
-4,007 Reduced 0.39%
1,036,341 $58.3 Million
Q3 2017

Nov 03, 2017

BUY
$58.67 - $63.13 $61 Million - $65.7 Million
1,040,348
1,040,348 $66.6 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.